- Home
- ROIV vs AGI Comparison
ROIV vs AGI Comparison
Compare ROIV & AGI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ROIV | AGI |
|---|---|---|
| Founded | 2014 | 2003 |
| Country | United Kingdom | Canada |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Precious Metals |
| Sector | Health Care | Basic Materials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 14.1B | 14.8B |
| IPO Year | N/A | 1999 |
Fundamental Metrics
Financial Performance| Metric | ROIV | AGI |
|---|---|---|
| Price | $22.56 | $38.48 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 8 | 3 |
| Target Price | $24.31 | ★ $41.00 |
| AVG Volume (30 Days) | ★ 8.2M | 2.6M |
| Earning Date | 02-09-2026 | 10-29-2025 |
| Dividend Yield | N/A | ★ 0.26% |
| EPS Growth | N/A | ★ 112.89 |
| EPS | N/A | ★ 1.28 |
| Revenue | $20,329,000.00 | ★ $1,609,300,000.00 |
| Revenue This Year | N/A | $40.10 |
| Revenue Next Year | $376.94 | $33.02 |
| P/E Ratio | ★ N/A | $30.00 |
| Revenue Growth | N/A | ★ 31.30 |
| 52 Week Low | $8.73 | $17.80 |
| 52 Week High | $23.47 | $39.44 |
Technical Indicators
Market Signals| Indicator | ROIV | AGI |
|---|---|---|
| Relative Strength Index (RSI) | 61.61 | 65.08 |
| Support Level | $21.60 | $36.86 |
| Resistance Level | $23.47 | $39.44 |
| Average True Range (ATR) | 0.88 | 1.29 |
| MACD | 0.06 | 0.04 |
| Stochastic Oscillator | 69.09 | 76.05 |
Price Performance
Historical ComparisonAbout ROIV Roivant Sciences Ltd.
Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.
About AGI Alamos Gold Inc.
Alamos Gold Inc acquires, explores, and produces gold and other precious metals, and operates in two principal geographic areas: Canada and Mexico. The company has four operating segments being Young-Davidson, Island Gold and Magino mines operate in Canada, and the Mulatos mine operates in Sonora, Mexico. The company generates maximum revenue from the Mulatos mines.